The appearance was part of LHL’s campaign "Hennes Hjerte. Like Viktig" and highlighted a message that cannot be emphasized often enough:

Women and men are not always affected by heart disease in the same way.

Women and men are biologically different, yet much of today’s cardiology and cardiovascular research is still based on men. This means that symptoms, risk factors, disease trajectories, and treatment responses can present very differently in women. Far too many women experience breathlessness, fatigue, discomfort, and vague symptoms for a long time, assuming they are due to stress, poor fitness, or age—when, in reality, it may be the heart signalling for help.

Cardiovascular disease remains one of the most common causes of death among women in Norway. At the same time, only about one in three participants in heart research studies are women. When research on women’s hearts is lacking, we also lack the knowledge needed to provide accurate diagnosis and the most effective treatment and medication for women.
 

LHL, innlegg (facebook) (external link)

God Morgen Norge TV2 (external link)

LHL, Landsforeningen for hjerte, lunge og hjerneslag

Eva Gerdts, professor at the Center for Research on Heart Disease in Women

Women and men differ biologically more than previously believed. Factors related to sex chromosomes, sex hormones, and reproductive history influence women’s risk of cardiovascular disease, in addition to traditional risk factors such as hypertension, high cholesterol, smoking, and obesity. Women therefore have additional risk factors and often develop different variants of common cardiac conditions compared with men.
Women with heart disease often require different diagnostic approaches and treatment strategies. This applies to conditions such as myocardial infarction, heart failure, and atrial fibrillation. Increased research is essential to identify the most effective treatment for women with cardiovascular disease.